跳至主要内容
临床试验/CTRI/2026/01/100985
CTRI/2026/01/100985尚未招募2/3 期

A Randomized Controlled Single Blind Comparative Clinical Trial For Evaluating The Safety And Efficacy Of MAJOON-E-KUNDUR Versus NITROFURANTOIN In The Management Of TAADIYA-E-MAJRA-E-BAUL(Recurrent Urinary Tract Infection).

Government Nizamia Tibbi College and Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年3月9日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

Recurrent UTI’S are common and defined as more then two symptomatic episode occuring over 6 months or more than three symptomatic episodes over 12 months.

Urinary tract infection (UTI) is associated with multiplication of organisms in the Urinary tract, and is defined by the presence of more than 100000 organisms per ml in a mid stream Urine (MSU) of sample.

UTI remains the most common infection worldwide, which can occur in any time of an individual lifes.

Population studies from numerous countries have reported the prevalence of 13% in Hyderabad, with a female predominance.

Despite widespread use of antibiotics, it leads to resistance and side effects, necessitates exploring alternative therapies to find natural treatments that are effective, safe, and reduce dependency on antibiotics.

Unani formulations like Majoon-e-kundur known for it’s anti-inflammatory & anti-microbial properties former purifies blood and corrects infection, may offer a, safer alternative.

This study aims for scientific validation through RCT essential to establish it’s therapeutic potential.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)

入选标准

  • 1.Age group from 18 to 50 years.
  • 2.Either Gender.
  • 3.Patients with Symptoms of Dysuria, Burning micturition with or without fever.
  • Frequency of micturition & Urgency.
  • 4.Patient with recurrent UTI.
  • 5.Patient with positive Urine Dipstick & Urine Culture.

排除标准

  • 1.Pregnant & Lactating Women, Children.
  • 2.Patients with Diabetic mellitus.
  • 3.Patients with Uncontrolled Hypertensive.
  • 4.Patient with Complicated UTI.
  • 5.Patient with Congenital abnormalities.
  • 6.Patient with Significant Pulmonary/Cardiovascular/ Hepato-renal Dysfunction/ Psychiatric illness Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies.
  • 7.Participant who had received any treatment within month of start of study.
  • Patient not willing to attend treatment schedule regularly.

研究者

发起方
Government Nizamia Tibbi College and Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Nadera Tarannum

Government Nizamia Tibbi College and Hospital

研究点 (1)

Loading locations...

相似试验